Meibomian Gland Dysfunction
Conditions
Interventions
Group A:Broadband Light
Group B:Narrow spectrum intense pulsed light
Sponsors
Peking University Third Hospital
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: (1) Aged=18 years old; (2) Have Ocular Symptoms; (3) Meibum Quality =1; (4) Meibomian Gland Expressibility =3; (5) The subject is willing to comply with the treatment and follow-up schedule, and participates voluntarily in this study.
Exclusion criteria
Exclusion criteria: (1) Acute inflammation; (2) Previous Ocular Surgery or Trauma; (3) Abnormal eyelid such as the eyelid closure insufficiency, entropion or ectropion; (4) Pregnancy and nursing. (5) Have systemic immune related diseases, such as sjogren's syndrome, Stevens Johnson syndrome, rheumatism, etc.; (6) Have dry eye physiotherapy or anti-inflammation drugs within 1 month; (7) Other conditions judged by the researcher as unsuitable for this clinical trial.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| OSDI;Meibum Quality;meibomian gland expressibility; | — |
Secondary
| Measure | Time frame |
|---|---|
| standard vision;intraocular pressure;BUT;corneal fluorescein staining;TMH;meibomian gland dropout;conjunctival congestion;confocal microscopy of meibomian glands;slit lamp image; | — |
Countries
China
Contacts
Public ContactXuemin Li
Peking University Third Hospital
Outcome results
None listed